Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials-Reference-Cited by-同舟云学术

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials

Published:2012-09 Issue:9 Volume:14 Page:992-999
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Latini Roberto¹,Gullestad Lars²³,Masson Serge¹,Nymo Ståle Haugset⁴,Ueland Thor⁴,Cuccovillo Ivan⁵,Vårdal Mari⁶,Bottazzi Barbara⁵,Mantovani Alberto⁵⁷,Lucci Donata⁸,Masuda Nobuhito⁹,Sudo Yukio⁹,Wikstrand John¹⁰,Tognoni Gianni¹¹,Aukrust Pål³¹²,Tavazzi Luigi¹³,

Affiliation:

1. Department of Cardiovascular Research; Istituto di Ricerche Farmacologiche Mario Negri; via Giuseppe La Masa 19 20156 Milan Italy

2. Department of Cardiology; Oslo University Hospital; Rikshospitalet, Oslo Norway

3. Faculty of Medicine; University of Oslo; Oslo Norway

4. Research Institute for Internal Medicine; Rikshospitalet, Oslo Norway

5. Istituto Clinico Humanitas; Rozzano Italy

6. Department of Biostatistics; Oslo University Hospital Rikshospitalet; Oslo Norway

7. Department of Translational Medicine; Università degli Studi di Milano; Milan Italy

8. ANMCO Research Center; Florence Italy

9. Perseus Proteomics; Tokyo Japan

10. Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy; Gothenburg University; Gothenburg Sweden

11. Consorzio Mario Negri Sud; Santa Maria Imbaro; Italy

12. Section of Clinical Immunology and Infectious Diseases; Oslo University Hospital Rikshospitalet; Oslo Norway

13. GVM Hospitals of Care and Research; Ettore Sansavini Health Science Foundation; Cotignola Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfs092/fullpdf

Reference32 articles.

1. The role of monocytes and inflammation in the pathophysiology of heart failure;Wrigley;Eur J Heart Fail,2011

2. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study;Vasan;Circulation,2003

3. C-reactive protein in heart failure: prognostic value and the effect of valsartan;Anand;Circulation,2005

4. Soluble CD40 ligand in acute and chronic heart failure;Ueland;Eur Heart J,2005

5. Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure;Radauceanu;J Card Fail,2008

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pentraxin 3 in Myocarditis: Proof-of-Principle Assessment as a Diagnostic and Prognostic Biomarker;Journal of Cardiovascular Translational Research;2024-03-28

2. Effects of Immunomodulatory Drugs on Cardiac and Immune Function in Patients with Heart Failure: A Meta-Analysis of Randomized Controlled Trials;J BIOL REG HOMEOS AG;2024

3. A Set of Possible Markers for Monitoring Heart Failure and Cognitive Impairment Associated: A Review of Literature from the Past 5 Years;Biomolecules;2024-02-03

4. Pentraxin 3: A promising therapeutic target for cardiovascular diseases;Ageing Research Reviews;2024-01

5. Targeting Key Inflammatory Mechanisms Underlying Heart Failure: A Comprehensive Review;International Journal of Molecular Sciences;2023-12-29